Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study
Year: 2010
Type: article
Institutions: Centro de Investigación Biomédica en Red de Salud Mental, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Belgium), Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: aripiprazole, bipolar mania, bipolar I disorder, lithium, valproic acid, adjunctive antipsychotic therapy, partial response, long-term tolerability, extrapyramidal symptoms, akathisia, weight gain, Young Mania Rating Scale, open-label extension, insomnia, tremor, antiepileptic drugs, antipsychotic drugs, mood stabilizers
Open Access status: closed
Funder: European Psychiatric Association
OpenAlex ID: W1994529784
